Innovation Pharma to increase dosing frequency in Covid-19 drug trial,

April 6, 2021 April 6, 2021

Innovation Pharmaceuticals is set to increase dosing frequency in Phase II clinical trial of a drug candidate, Brilacidin, for treating moderate-to-severe …, Innovation Pharmaceuticals is set to increase dosing frequency in Phase II clinical trial of a drug candidate, Brilacidin, for treating moderate-to-severe …, Read More

Cardiol Therapeutics Announces Topline Results from Phase I Single and Multiple Ascending ...
on April 12, 2021
"Study results support the dosing regimen being utilized in our U.S. Phase II/III clinical trial investigating the cardioprotective properties of CardiolRx in ...
London healthcare VC snaps up Velocity Clinical Research after COVID-19 changes the trial ...
on April 12, 2021
U.K.-based healthcare venture firm GHO Capital has bought out siteless trial specialist Velocity Clinical Research from its D.C.-based VC owner ...
9 Meters Biopharma, Inc. and Celiac Disease Foundation Announce Collaboration to Support ...
on April 12, 2021
... to Support Clinical Trial Enrollment in 9 Meters' Phase 3 CeDLara Study ... alternative therapy to treat celiac disease is in Phase 3 clinical trials.
Marinus Pharmaceuticals Bolsters Leadership Team with Two New Appointments
on April 12, 2021
... actions or advice of the U.S. Food and Drug Administration may affect the design, initiation, timing, continuation and/or progress of clinical trials or ...
Predicting Immunotherapy Resistance in Bladder Cancer
on April 12, 2021
New research from the Mount Sinai Health System identified potential ... Researchers analyzed bulk RNA sequencing data from two clinical trials of ...
Oncolytics Biotech® and SOLTI Achieve Primary Endpoint in AWARE-1 Study
on April 12, 2021
(NASDAQ: ONCY) (TSX: ONC), together with SOLTI, recently announced new clinical data from the AWARE-1 window-of-opportunity breast cancer ...
BriaCell Therapeutics Presents Clinical Data at the American Association for Cancer Research ...
on April 12, 2021
Clinical and pathological data presented from the clinical trials of Bria-IMT™ alone and in combination with immune checkpoint inhibitors in advanced ...
Roche reports positive results from Covid-19 antibodies trial
on April 12, 2021
Roche chief medical officer and Global Product Development head Levi Garraway said: “Today's data confirm the potential dual value of casirivimab ...
The COVID-19 vaccines are highly effective. Here's what the numbers really mean.
on April 12, 2021
No vaccine's real-world results quite measure up to its performance in a clinical trial. All the more reason to make that appointment, these researchers ...
‎Mantle Cell Lymphoma CancerCare Connect Education Workshops: Update on Clinical Trials ...
on April 12, 2021
Overview of Clinical Trials and Why They Are Important, in the Context of COVID-19 * Understanding Your Treatment Options, including Clinical Trials ...
Could infrared light help people with dementia?
on April 12, 2021
He met Berman at a Department of Defense meeting, and their collaboration ensued. According to clinicaltrials,gov, the government list of clinical trials, ...
Cardiff Oncology Announces Onvansertib Phase 1b/2 Data that Continues to Demonstrate Robust ...
on April 12, 2021
Patients enrolled in the ongoing Phase 1b/2 trial receive onvansertib in ... Additionally, there are no guarantees that future clinical trials will be ...

S	M	T	W	T	F	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30

Covigilant Research, LLC

For Investigators >> Free Study List

Advertise Your Study>> For Free

Get The Latest >> COVID-19 News

Covigilant Research, LLC

Committed To Working Together

Innovation Pharma to increase dosing frequency in Covid-19 drug trial,